Technology

R3CE
is here to change the world

Our core technology "Rapid Reproducible Rare Cell 3D Expansion" (R3CE) is a powerful tool for 3D cell culture that can help researchers to gain insight into cancer research, clinical treatments, and drug discovery.

Technology
What is R3CE?

R3CE is a revolutionary scaffold-free single-cell proliferation 3D cell culture platform that can quickly and reliably culture spheroids from CTC, biopsy, and cell line samples with a high yield and proliferation rate. This technology is highly efficient and can be applied to a variety of applications, such as cell-based drug tests, multiomics, and oncology research. R3CE is the unique technology on the market, making it a must-have for any laboratory.

Single-cell proliferation on R3CE​

Single clone on R3CE​
High production on R3CE​

R3CE delivers high yield and consistent results.​
*Videos from 20X image inverted microscope​

R3CE plates​

R3CE plate features​
Clinical grade ready​
No animal or bio-derived components​
Easy QC​
Compatible with all culture dish configurations ​
R3CE culture results​
Extremely consistent
High Yield​
Uniform Size​
Compatible with all culture dish configurations ​

Revolutionary​ CTC
culture by liquid biopsy​

Circulating tumor cells (CTC) is valued as a promising candidate for cancer detection and prognosis, yet captured numbers are often limited. Our breakthrough single-cell proliferation technology makes R3CE applicable to even CTCs and stem cells. Over 10 to 14 days, isolated CTCs cultivated on R3CE plates can provide sufficient genomic information available for clinical drug screening. ​

Learn More

REVOLUTIONARY
CTC culture by R3CE

Circulating tumor cells (CTC) is valued as a promising candidate for cancer detection and prognosis, yet captured numbers are often limited. Our breakthrough single-cell proliferation technology makes R3CE applicable to even CTCs and stem cells . Over 10 to 14 days, isolated CTCs cultivated on R3CE plates can provide sufficient genomic information available for clinical drug screening.

Patient-derived Head and Neck Cancer CTC cultured on R3CE before and after 2 weeks

Our technology is at the junction of all biotech things

R3CE enables a high successful rate in spheroid culture formation, specific biomarker characterization, spheroid-based activity assay test, and tumor banking. R3CE accepts all forms of sample sources, including liquid biopsy, core needle biopsy, tissue, etc. The 3D cultured spheroids also demonstrate feasibility in rapid PDx formation and enable studies from the same patient with the paired specimen (normal/tumor/LN).​

Venture beyond the limitations of traditional cell banking, cell therapy, and precision medicine. While our core service lies in cell-based drug tests, we are also proud to advance all your R&D needs by providing customized 3D solutions. Integrate R3CE to your current projects and receive fast, consistent, and reliable 3D cell culture results to translate your research ideas into reality.

Sample from

CTC, Stem Cell, Tissue, Liquid Biopsy​

R3CE culture

Single cell cultured into spheroids Applicable to CTCs

Animal-free testing​

• 3D cell banking​
• Tumor banking reconstruct
• Tumor microenvironment ​

Precision medicine​

• Cell-based drug test​
• Pure tumor spheroid model​
• Multiomics​

Regenerative medicine​

• Cell production​
• Cell therapy​
• Rare stem cell proliferation

Learn more

Get in touch